Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Juan J.

Juan J. Depablo, Madison, WI US

Patent application numberDescriptionPublished
20080220520CRYOPRESERVATION OF HUMAN EMBRYONIC STEM CELLS IN MICROWELLS - The present invention relates to methods and structures for preparing stem cells for use in cryopreservation methods. Stem cell colonies are provided between first and second matrix portions and are exposed to a carbohydrate-containing cryoprotecting medium and a freezing medium. The methods of the invention yield cryopreserved cells that maintain cell viability and exhibit limited cell differentiation after freezing and thawing, facilitating storage, shipping and handling of embryonic stem cell stocks and lines for research and therapeutics.09-11-2008
20090053268NANOPARTICLE MODIFIED LUBRICANTS AND WAXES WITH ENHANCED PROPERTIES - The present invention provides compositions and products, such as waxes and lubricants, comprising a plurality of nanoparticles dispersed in a continuous phase comprising a vegetable oil derived material, such as one or more vegetable oils or a synthetic product derived from one or more vegetable oils. Incorporation of nanoparticles in the present compositions is beneficial for providing mechanical, thermal and/or chemical properties useful for a selected product or product application. In some compositions of the present invention, for example, incorporation of the nanoparticle component provides compositions derived from one or more vegetable oils exhibiting enhanced mechanical stability, hardness, viscosity, thermal stability and mechanical strength.02-26-2009
20100197013METHOD FOR CULTURING STEM CELLS - A three-dimensional microwell system that supports long term pluripotent cell culture and formation of homogeneous embryoid bodies (EBs) is described. Microwell-cultured pluripotent cells remain viable and undifferentiated for several weeks in culture and maintain undifferentiated replication when passaged to Matrigel®-coated, tissue culture-treated polystyrene dishes. Microwell-cultured pluripotent cells maintain pluripotency, differentiating to each of the three embryonic germ layers. Pluripotent cell aggregates released from microwells can be passaged for undifferentiated replication or differentiated to monodisperse EBs. The ability to constrain pluripotent cell growth in three dimensions advantageously provides for more efficient, reproducible culture of undifferentiated cells, high-throughput screening, and the ability to direct pluripotent cell differentiation by generating monodisperse EBs of a desired size and shape. Cardiomyocyte-rich EBs are obtained from pluripotent cells cultured in microwells of defined size and shape.08-05-2010

Patent applications by Juan J. Depablo, Madison, WI US

Juan J. De Pablo, Madison, WI US

Patent application numberDescriptionPublished
20080299353Methods and compositions for forming patterns with isolated or discrete features using block copolymer materials - Methods of directing the self assembly of block copolymers on chemically patterned surfaces to pattern discrete or isolated features needed for applications including patterning integrated circuit layouts are described. According to various embodiments, these features include lines, t-junctions, bends, spots and jogs. In certain embodiments a uniform field surrounds the discrete feature or features. In certain embodiments, a layer contains two or more distinct regions, the regions differing in one or more of type of feature, size, and/or pitch. An example is an isolated spot at one area of the substrate, and a t-junction at another area of the substrate. These features or regions of features may be separated by unpatterned or uniform fields, or may be adjacent to one another. Applications include masks for nanoscale pattern transfer as well as the fabrication of integrated circuit device structures.12-04-2008
20090075374METHODS OF GENERATING EPITHELIAL LINEAGE CELLS FROM EMBRYOID BODIES AND PLURIPOTENT CELLS - Methods of generating p63-positive cells from embryoid bodies and pluripotent cells by culturing the cells in the presence of a retinoid and optionally a bone morphogenetic protein, such that the cells express at least p63. The p63-positive cells can be further cultured without the retinoid and optional bone morphogenetic protein to K14-positive cells. The K14-positive cells can be further cultured into various terminally differentiated cell types of the epithelial lineage.03-19-2009
20090087653Fabrication of complex three-dimensional structures based on directed assembly of self-assembling materials on activated two-dimensional templates - Methods of fabricating complex three-dimensional structures on patterned substrates and related compositions are provided. The methods involve depositing on the substrate a block copolymer material that is “mismatched” to the substrate pattern, and then ordering the material to form a complex three-dimensional structure. According to various embodiments, the copolymer material mismatches the substrate pattern in that the symmetry and/or length scale of its bulk morphology differs from that of the pattern. When ordered, a balance between the physics that determines the bulk block copolymer morphology and the physics that determines the substrate surface interfacial interactions results in a thermodynamically stable complex three-dimensional film that varies in a direction perpendicular to the substrate and has a morphology that differs from its bulk morphology.04-02-2009
20090087664Directed assembly of triblock copolymers - Methods of directed self-assembly of multi-block (i.e., triblock and higher-order) copolymers on patterned substrates and related compositions are provided. According to various embodiments, the methods involve depositing copolymer materials on substrates configured to drive the assembly of micro-phase separated films that exhibit the same morphology as that copolymer materials in the bulk. In certain embodiments, binary patterns are used to drive the triblock copolymer films. The binary two-dimensional surface patterns are transformed into three-component and three-dimensional structures throughout the thickness of the overlying copolymer films.04-02-2009
20090196488DENSITY MULTIPLICATION AND IMPROVED LITHOGRAPHY BY DIRECTED BLOCK COPOLYMER ASSEMBLY - Methods to pattern substrates with dense periodic nanostructures that combine top-down lithographic tools and self-assembling block copolymer materials are provided. According to various embodiments, the methods involve chemically patterning a substrate, depositing a block copolymer film on the chemically patterned imaging layer, and allowing the block copolymer to self-assemble in the presence of the chemically patterned substrate, thereby producing a pattern in the block copolymer film that is improved over the substrate pattern in terms feature size, shape, and uniformity, as well as regular spacing between arrays of features and between the features within each array compared to the substrate pattern. In certain embodiments, the density and total number of pattern features in the block copolymer film is also increased. High density and quality nanoimprint templates and other nanopatterned structures are also provided.08-06-2009
20090206054MATERIALS AND METHODS FOR CREATING IMAGING LAYERS - The present invention provides patterned features of dimensions of less than 50 nm on a substrate. According to various embodiments, the features may be “Manhattan” style structures, have high aspect ratios, and/or have atomically smooth surfaces. The patterned features are made from polymer brushes grafted to a substrate. In some embodiments, the dimensions of the features may be determined by adjusting the grafting density and/or the molecular weight of the brushes. Once the brushes are patterned, the features can be shaped and reshaped with thermal or solvent treatments to achieve the desired profiles. The chemical nature of the polymer brush is thus independent of the patterning process, which allows for optimization of the polymer brush used for specific applications. Applications include masks for pattern transfer techniques such as reactive ion etching.08-20-2009
20100221834LIQUID CRYSTALLINE SUBSTRATES FOR CULTURING CELLS - The present invention is directed to liquid crystalline substrates useful in the culture of cells and methods of their use. In certain embodiments, the invention provides methods and devices for imaging changes (e.g., reorganization) of extracellular matrix components by living cells.09-02-2010

Patent applications by Juan J. De Pablo, Madison, WI US

Juan J. Diaz-Mochon, Edinburgh GB

Patent application numberDescriptionPublished
20110028337NUCLEOBASE CHARACTERISATION - The present invention provides modified nucleobase compounds, modified nucleic acid mimetic compounds and various uses thereof. In addition, the invention provides methods for nucleobase characterisation, SNP characterisation and nucleic acid sequencing.02-03-2011

Juan J. Ferrada, Knoxville, TN US

Patent application numberDescriptionPublished
20090104111Carbonate Thermochemical Cycle for the Production of Hydrogen - The present invention is directed to a thermochemical method for the production of hydrogen from water. The method includes reacting a multi-valent metal oxide, water and a carbonate to produce an alkali metal-multi-valent metal oxide compound, carbon dioxide, and hydrogen.04-23-2009

Juan J. Hernandez Sierra, Bogota CO

Patent application numberDescriptionPublished
20110039293Effervescent Solid Pharmaceutical Composition Comprising Dextrose and Process for its Preparation - The present invention is related to the medicine field. Specifically, the present Invention is related with an effervescent solid pharmaceutical composition of dextrose having as purpose determining the metabolized glucose levels in a patient with diabetes or glucose metabolism related conditions, in a simple and effective manner with respect to the conventional products of this kind. Accordingly, the present invention provides a novel product allowing the medical professional or physician of a clinic laboratory to determine in a quantitative, economic, efficient, fast and in a single manner, the clinical conditions of a patient regarding the glucose level and the pancreas ability to eliminate the unnecessary sugars in terms of time. Furthermore, the present invention provides a novel process for preparing the novel effervescent solid pharmaceutical formulation of dextrose.02-17-2011

Juan J. Hierro Sureda, Madrid ES

Patent application numberDescriptionPublished
20110113205DATA STORAGE DEVICE - A data storage device connectable to an electronic device and a remote storage serve, which comprises memory managing means configured to receive a request for a piece of information from the electronic device and if said piece of information is stored both in a local memory of the data storage device and in the remote server, retrieving the requested piece of information from the local memory to reduce latency.05-12-2011

Juan J. Lechuga, Santa Ana, CA US

Patent application numberDescriptionPublished
20090187079SURGICAL INSTRUMENT ACCESS DEVICE - Embodiments of an access device system useful for single or limited port procedures comprises a retractor and a gel cap removably coupled to the retractor. The gel cap comprises a gel pad that acts as an artificial body wall, through which instruments may be inserted into a body cavity, either directly or through one or more trocars. The gel pad permits flexible instrument placement, as well as translational and angular degrees of freedom for the instruments while maintaining a gas tight seal.07-23-2009

Juan J. Lucena, Madrid ES

Patent application numberDescriptionPublished
20100022394PRODUCTS FOR THE TREATMENT OF THE IRON CHLOROSIS - The present invention consists on the synthesis of new products for the treatment of the iron chlorosis. These products may have improved properties regarding the currently known treatments. The new products are non-symmetrical ethylene diamino hidroxyphenyl acetic acid derivatives possessing only five coordination sites able to chelate metals.01-28-2010

Juan J. Noguera Serra, Dublin IE

Patent application numberDescriptionPublished
20110124333FEMTOCELL CONFIGURATION USING SPECTRUM SENSING - An embodiment of the present invention provides for the ad-hoc configuration of femtocells using spectrum sensing for the selection of spectrum channels. One or more embodiments of the invention determine frequency bands that are not reserved by macrocells in a location, and perform spectrum sensing to determine communication channels in unreserved frequency bands that are being used by other femtocells in range. In this manner, femtocells can be deployed and configured in an ad-hoc manner without external coordination or control between deployed femtocells.05-26-2011

Juan J. Perez-Villar, Valencia ES

Patent application numberDescriptionPublished
20090042226Identification and cloning of a full-length human CLNK-related gene, MIST (MAST cell immunoreceptor signal transducer) - The present invention describes a newly discovered full-length polynucleotide encoding an SH2 domain-containing adapter protein, called human MIST, cloned, isolated and identified from a human spleen cDNA library. Also described are the MIST polypeptide sequence, expression vectors, host cells, agonists, antagonists, antisense molecules, and antibodies related to the polynucleotide and/or polypeptide of the present invention. Novel splice variant forms of human MIST are provided. Methods for screening for modulators, particularly inhibitors, of the MIST protein and use of the human MIST polynucleotide and polypeptide for therapeutics and diagnostics are described.02-12-2009

Juan J. Perez-Villar, Los Angeles, CA US

Patent application numberDescriptionPublished
20090004109Antibodies and Molecules Derived Therefrom that Bind to Steap-1 Proteins - Antibodies and molecules derived therefrom that bind to novel STEAP-1 protein, and variants thereof, are described wherein STEAP-1 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, STEAP-1 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The STEAP-1 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with STEAP-1 can be used in active or passive immunization.01-01-2009

Patent applications by Juan J. Perez-Villar, Los Angeles, CA US

Juan J. Reinoso, Houston, TX US

Patent application numberDescriptionPublished
20100305250C7-C12 Secondary Alcohol Esters of Cyclohexanoic Acid - C7-C12 secondary alcohol esters of cyclohexanecarboxylic acids are especially useful as plasticizers for PVC and other plasticizable polymers. In embodiments, these plasticizers are useful in plastisol formulations to help improved processability of flexible12-02-2010